Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGFβ pathway inhibition.
Maher JM, Zhang R, Palanisamy G, Perkins K, Liu L, Brassil P, McNamara A, Lo A, Hughes AD, Kanodia J, Kulyk S, Nikula KJ, Dengler HS, Scandurra A, Lua I, Harstad E.
Maher JM, et al. Among authors: perkins k.
Toxicol Appl Pharmacol. 2022 Mar 1;438:115905. doi: 10.1016/j.taap.2022.115905. Epub 2022 Feb 3.
Toxicol Appl Pharmacol. 2022.
PMID: 35122773
Free article.